haw-AD-14

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug Namehaw-AD-14
Drug Alias NameAlzheimer's disease therapy (CoPlex)Alzheimer's disease therapy (Hawthorn)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMicrotubule-associated protein tau inhibitorsBeta amyloid A4 protein inhibitors
TargetsMicrotubule-associated protein tauBeta amyloid A4 protein
Therapy Area/IndicationsAlzheimer Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesCoPlex Therapeutics LLC
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesHawthorn Pharmaceuticals IncCoPlex Therapeutics LLC
Active IndicationsN/A
Inactive IndicationsAlzheimer Disease

Other Information

ATC CodeN/A
Related LinksN/A